Solas Capital Management, LLC Reports New 7.1% Stake in MAIA Biotechnology, Inc.

On May 15, 2026, Solas Capital Management, LLC and Frederick Tucker Golden filed a Schedule 13G regarding their holdings in MAIA Biotechnology, Inc. (MAIA). The filing discloses that the reporting persons have acquired a beneficial ownership of 4,297,004 shares of common stock, representing 7.1% of the company's outstanding shares as of March 31, 2026. This position marks a new significant holding for the investment manager, as the previous reported ownership was 0%. Solas Capital Management, LLC serves as the investment manager to a private fund and sub-adviser to another, holding these securities for the benefit of their investors. Frederick Tucker Golden, as the Portfolio Manager of Solas Capital Management, shares voting and dispositive power over the reported shares. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The ownership percentage is based on 60,671,491 shares of common stock outstanding as reported by the issuer in March 2026.